Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Withdrawn 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Motor Activity 9Breast Neoplasms 7Neoplasms 4Fatigue 3Recurrence 2Body Weight 2Weight Loss 1Warts 1Vomiting 1Prostatic Neoplasms 1Polycystic Ovary Syndrome 1Ovarian Neoplasms 1Neoplasm Metastasis 1Nausea 1Multiple Myeloma 1Lymphoma, Follicular 1Lymphoma 1Lung Neoplasms 1Leukemia 1Insulin Resistance 1Hodgkin Disease 1Hematologic Neoplasms 1Hematologic Diseases 1Head and Neck Neoplasms 1Dementia 1Colonic Neoplasms 1Cognitive Dysfunction 1Asthenia 1Anomia 1Alzheimer Disease 1

Interventions

Dexamethasone 23Ondansetron 12Palonosetron 11Aprepitant 9Granisetron 7Olanzapine 5ramosetron 3netupitant, palosentron drug combination 3casopitant 3Radiotherapy 3fosaprepitant 2Thalidomide 2Prochlorperazine 2Electroacupuncture 2Dronabinol 2Analgesia 2Acupressure 2sinomenine 1netupitant 1lerisetron 1dolasetron 1dexamethasone acetate 1Tropisetron 1Therapeutics 1Taxes 1Tablets 1Surveys and Questionnaires 1Sugars 1Metoclopramide 1Hygiene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Vomiting × Exercise × Clear all
NCT00891761 2015-04-17

A Study of IV Casopitant for the Prevention of Nausea and Vomiting Caused By Cisplatin-Based Highly Emetogenic Chemotherapy

GlaxoSmithKline

Phase 3 Withdrawn
Thoracic

Lung Neoplasms, Nausea, Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡